These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 32376395)

  • 1. SARS-CoV-2 infection among patients with systemic autoimmune diseases.
    Emmi G; Bettiol A; Mattioli I; Silvestri E; Di Scala G; Urban ML; Vaglio A; Prisco D
    Autoimmun Rev; 2020 Jul; 19(7):102575. PubMed ID: 32376395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
    Zen M; Fuzzi E; Astorri D; Saccon F; Padoan R; Ienna L; Cozzi G; Depascale R; Zanatta E; Gasparotto M; Benvenuti F; Bindoli S; Gatto M; Felicetti M; Ortolan A; Campaniello D; Larosa M; Lorenzin M; Ramonda R; Sfriso P; Schiavon F; Iaccarino L; Doria A
    J Autoimmun; 2020 Aug; 112():102502. PubMed ID: 32527675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion.
    Sarzi-Puttini P; Marotto D; Antivalle M; Salaffi F; Atzeni F; Maconi G; Monteleone G; Rizzardini G; Antinori S; Galli M; Ardizzone S
    Autoimmun Rev; 2020 Jul; 19(7):102574. PubMed ID: 32376399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
    Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Tavoni A; Cecchetti R; Guiducci S; Ursini F; Caminiti M; Varcasia G; Gigliotti P; Pellegrini R; Olivo D; Colaci M; Murdaca G; Brittelli R; Mariano GP; Spinella A; Bellando-Randone S; Aiello V; Bilia S; Giannini D; Ferrari T; Caminiti R; Brusi V; Meliconi R; Fallahi P; Antonelli A;
    Clin Rheumatol; 2020 Nov; 39(11):3195-3204. PubMed ID: 32852623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
    Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thoughts on COVID-19 and autoimmune diseases.
    Askanase AD; Khalili L; Buyon JP
    Lupus Sci Med; 2020; 7(1):e000396. PubMed ID: 32341791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.
    Montero F; Martínez-Barrio J; Serrano-Benavente B; González T; Rivera J; Molina Collada J; Castrejón I; Álvaro-Gracia J
    Rheumatol Int; 2020 Oct; 40(10):1593-1598. PubMed ID: 32794113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.
    Sanchez-Piedra C; Diaz-Torne C; Manero J; Pego-Reigosa JM; Rúa-Figueroa Í; Gonzalez-Gay MA; Gomez-Reino J; Alvaro-Gracia JM;
    Ann Rheum Dis; 2020 Jul; 79(7):988-990. PubMed ID: 32503857
    [No Abstract]   [Full Text] [Related]  

  • 9. Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.
    Coskun Benlidayi I; Kurtaran B; Tirasci E; Guzel R
    Rheumatol Int; 2020 Oct; 40(10):1707-1716. PubMed ID: 32591970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes.
    Kastritis E; Kitas GD; Vassilopoulos D; Giannopoulos G; Dimopoulos MA; Sfikakis PP
    Rheumatol Int; 2020 Sep; 40(9):1353-1360. PubMed ID: 32654078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
    Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S
    Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD.
    Mihai C; Dobrota R; Schröder M; Garaiman A; Jordan S; Becker MO; Maurer B; Distler O
    Ann Rheum Dis; 2020 May; 79(5):668-669. PubMed ID: 32241792
    [No Abstract]   [Full Text] [Related]  

  • 13. Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.
    Bugatti S; De Stefano L; Bobbio-Pallavicini F; Montecucco C
    RMD Open; 2020 Oct; 6(3):. PubMed ID: 33087414
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis.
    Gendelman O; Amital H; Bragazzi NL; Watad A; Chodick G
    Autoimmun Rev; 2020 Jul; 19(7):102566. PubMed ID: 32380315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab.
    Cai S; Sun W; Li M; Dong L
    Clin Rheumatol; 2020 Sep; 39(9):2797-2802. PubMed ID: 32562070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Dose Prednisone for Treatment of Autoimmune Pancreatitis in a Patient with Coronavirus Disease 2019 (COVID-19) due to Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Liaquat H; Shupp B; Kapoor S; Matin A
    Am J Case Rep; 2020 Jul; 21():e926475. PubMed ID: 32692733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoimmune diseases in the context of pandemic COVID-19].
    Horisberger A; Moi L; Ribi C; Comte D
    Rev Med Suisse; 2020 Apr; 16(N° 691-2):827-830. PubMed ID: 32348045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.
    Kasperkiewicz M; Schmidt E; Fairley JA; Joly P; Payne AS; Yale ML; Zillikens D; Woodley DT
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e302-e303. PubMed ID: 32333823
    [No Abstract]   [Full Text] [Related]  

  • 19. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover.
    Soresina A; Moratto D; Chiarini M; Paolillo C; Baresi G; Focà E; Bezzi M; Baronio B; Giacomelli M; Badolato R
    Pediatr Allergy Immunol; 2020 Jul; 31(5):565-569. PubMed ID: 32319118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection during late pregnancy: a report of 18 patients from Wuhan, China.
    Zhang L; Dong L; Ming L; Wei M; Li J; Hu R; Yang J
    BMC Pregnancy Childbirth; 2020 Jul; 20(1):394. PubMed ID: 32641013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.